GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2.
Saved in:
| Title: | GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2. |
|---|---|
| Authors: | Mizrahi RA; GigaGen, Inc., South San Francisco, CA 94080, USA., Lin WY; Alira Health, Inc., Framingham, MA 01702, USA., Gras A; GigaGen, Inc., South San Francisco, CA 94080, USA., Niedecken AR; GigaGen, Inc., South San Francisco, CA 94080, USA., Wagner EK; GigaGen, Inc., South San Francisco, CA 94080, USA., Keating SM; GigaGen, Inc., South San Francisco, CA 94080, USA., Ikon N; GigaGen, Inc., South San Francisco, CA 94080, USA., Manickam VA; GigaGen, Inc., South San Francisco, CA 94080, USA., Asensio MA; GigaGen, Inc., South San Francisco, CA 94080, USA., Leong J; GigaGen, Inc., South San Francisco, CA 94080, USA., Medina-Cucurella AV; GigaGen, Inc., South San Francisco, CA 94080, USA., Benzie E; GigaGen, Inc., South San Francisco, CA 94080, USA., Carter KP; GigaGen, Inc., South San Francisco, CA 94080, USA., Chiang Y; GigaGen, Inc., South San Francisco, CA 94080, USA., Edgar RC; GigaGen, Inc., South San Francisco, CA 94080, USA., Leong R; GigaGen, Inc., South San Francisco, CA 94080, USA., Lim YW; GigaGen, Inc., South San Francisco, CA 94080, USA., Simons JF; GigaGen, Inc., South San Francisco, CA 94080, USA., Spindler MJ; GigaGen, Inc., South San Francisco, CA 94080, USA., Stadtmiller K; GigaGen, Inc., South San Francisco, CA 94080, USA., Wayham N; GigaGen, Inc., South San Francisco, CA 94080, USA., Büscher D; Grifols S.A., 08174 Sant Cugat del Vallès, Spain., Terencio JV; Grifols S.A., 08174 Sant Cugat del Vallès, Spain., Germanio CD; Vitalant Research Institute, San Francisco, CA 94118, USA., Chamow SM; Alira Health, Inc., Framingham, MA 01702, USA., Olson C; Alira Health, Inc., Framingham, MA 01702, USA., Pino PA; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX 78227, USA., Park JG; Disease Intervention and Prevention Program, Texas Biomedical Research Institute, San Antonio, TX 78227, USA., Hicks A; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX 78227, USA., Ye C; Disease Intervention and Prevention Program, Texas Biomedical Research Institute, San Antonio, TX 78227, USA., Garcia-Vilanova A; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX 78227, USA., Martinez-Sobrido L; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.; Disease Intervention and Prevention Program, Texas Biomedical Research Institute, San Antonio, TX 78227, USA., Torrelles JB; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.; Disease Intervention and Prevention Program, Texas Biomedical Research Institute, San Antonio, TX 78227, USA., Johnson DS; GigaGen, Inc., South San Francisco, CA 94080, USA., Adler AS; GigaGen, Inc., South San Francisco, CA 94080, USA. |
| Source: | Pathogens (Basel, Switzerland) [Pathogens] 2022 Jul 19; Vol. 11 (7). Date of Electronic Publication: 2022 Jul 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101596317 Publication Model: Electronic Cited Medium: Print ISSN: 2076-0817 (Print) Linking ISSN: 20760817 NLM ISO Abbreviation: Pathogens Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2076-0817 |
|---|---|
| DOI: | 10.3390/pathogens11070806 |
